Elicio (ELTX) Director Yekaterina Chudnovsky Receives 21,750-Share Award

What Happened

• Yekaterina Chudnovsky, a non‑employee director and 10% owner of Elicio Therapeutics (ELTX), received a grant of 21,750 shares in the form of a stock option/award on 2026-08-31.
• The award is reported at $0.00 per share (derivative grant); reported total value = $0 (this reflects an option/award, not a cash purchase or sale).

Key Details

• Transaction type/date: Award/Grant (code A) on 2026-08-31; Form 4 filed 2026-09-02 (appears timely).
• Shares/price: 21,750 shares, $0.00 per share (derivative award).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote summary: The option is the annual non‑employee director equity award and vests in full on the earlier of (A) August 31, 2027 (one‑year anniversary) or (B) the 2027 annual meeting, subject to continued service. The filing notes no additional equity award will be made in connection with the 2026 annual meeting.
• Filing timeliness: Form filed two days after the grant date; no late-filing flag was provided.

Context

• This was a compensation award (an option grant) rather than an open‑market purchase or sale, so it primarily reflects director compensation, not an immediate buy/sell signal.
• The option must vest before it can be exercised; there is no indication of exercise or sale in this filing.
• As a reported 10% owner, Chudnovsky is a significant holder; this grant increases her potential future stake only upon vesting/exercise.